Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Fidia Farmaceutici S.p.A.
Sponsor

Fidia Farmaceutici S.p.A.

Italy Via Ponte Della Fabbrica 3 A, 35031 Abano Terme, Italy

About the sponsor

Clinical research includes treatment approaches for BCG-unresponsive carcinoma in situ of the bladder with or without Ta-T1 papillary disease, reflecting interest in difficult-to-treat non-muscle-invasive urothelial carcinoma.

  • Carcinoma in situ of the bladder
  • Non-muscle-invasive bladder cancer
  • Intravesical therapy

The sponsor’s activity in this area is centered on bladder-preserving oncology and local treatment options for resistant disease.

About Specializations

Fidia Farmaceutici S.p.A. runs clinical trials in conditions such as Peyronie's disease, Back pain, Major depression, Bladder cancer stage 0 with cancer in situ, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Peyronie's disease

Recruiting

Study on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase and Alprostadil for Patients with Peyronie's Disease

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alprostadil
  • Sponsor:Fidia Farmaceutici S.p.A.

Back pain

Recruiting

Study on Tricortin 1000, Diclofenac Sodium, and Paracetamol for Patients with Chronic Low Back Pain

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyanocobalamin
  • Sponsor:Fidia Farmaceutici S.p.A.

Major depression

Recruiting

Study on the Effectiveness of Hypothalamic Phospholipids and Citalopram for Treating Major Depressive Disorder in Elderly Patients

Registered drug
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Citalopram Hydrobromide
  • Sponsor:Fidia Farmaceutici S.p.A.

Bladder cancer stage 0 with cancer in situ

Not recruiting

Study of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel Obaluronate
  • Sponsor:Fidia Farmaceutici S.p.A.

Dupuytren's contracture

Not recruiting

Study on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase for Patients with Dupuytren's Contracture

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Vibrio Alginolyticus Collagenase
  • Sponsor:Fidia Farmaceutici S.p.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.